🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Norway / NCT05697250
Recruiting Not applicable

High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy

NCT05697250 · tracked via the Priya Life Science Norway tracker
Phase
Not applicable
Started
2023-01-23
Last updated
2025-03-05

Condition(s) studied

Renal Stone

Investigational drug(s) / intervention(s)

Laser power settings (Thulium Fiber Laser)

Laser power settings (Thulium Fiber Laser): Ureteroscopic lithotripsy using low power laser settings (0.4 - 0.6 J at 10 Hz corresponding to 2.4 - 6.0 Watts) or high power laser settings (0.4 J at 40 Hz, 0.6 J at 30 Hz or 0.8 J at 20 Hz corresponding to 16 - 18 Watts).

Study summary

The primary aim of the study is to compare the operative times following ureteroscopic lithotripsy for renal stones with Thulium Fiber Laser using low and high power settings.

Secondary aims are to compare the results of low and high power settings in terms of stone free rates, laser time, laser activation patterns, intraoperative and postoperative complications.

Patients ≥ 18 years with renal stones (8-25 mm) scheduled for ureteroscopic lithotripsy at the Day Surgery Clinic at Haukeland University Hospital in Bergen, Norway, are eligible for inclusion in the study. After written consent and inclusion, patients are randomised to laser lithotripsy using either low power settings (Group 1: 4-6 Watt, short pulse mode) or high power settings (Group 2: 16-18 Watt, short pulse mode). The ureteroscopic procedures are performed in general anaesthesia using a standardised technique. All patients are followed up with a low dose CT scan 3 months post endoscopically to assess stone free status as well as a consultation at the outpatient clinic.

Results and data for the two randomisation groups are compared according to the aims of the study.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital Exclusion Criteria: * Concomitant ureteral stone * Urinary diversion * Active infection * Untreated cancer in the upper urinary tract

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Haukeland University Hospital Bergen Vestland Recruiting

More Haukeland University Hospital trials in Norway

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05697250 on ClinicalTrials.gov ↗ ← All trials in Norway